These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37321454)
21. Vaccine-derived varicella zoster infection in a kidney transplant recipient after zoster vaccine live administration. Ortiz-Brizuela E; Leal-Vega F; Cuellar-Rodríguez J; Bobadilla-Del-Valle M; Ponce-de-León A Vaccine; 2019 Jun; 37(27):3576-3579. PubMed ID: 31109718 [TBL] [Abstract][Full Text] [Related]
22. Attenuated varicella virus vaccine in children with renal transplants. Zamora I; Simon JM; Da Silva ME; Piqueras AI Pediatr Nephrol; 1994 Apr; 8(2):190-2. PubMed ID: 8018498 [TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients. Groeneweg L; Loeffen YGT; Versluys AB; Wolfs TFW Vaccine; 2021 Jun; 39(25):3338-3345. PubMed ID: 33992440 [TBL] [Abstract][Full Text] [Related]
24. Early experience with varicella vaccination in pediatric heart transplant recipients. Dipchand AI; Seifert-Hansen M J Heart Lung Transplant; 2022 Aug; 41(8):1023-1026. PubMed ID: 35279390 [TBL] [Abstract][Full Text] [Related]
25. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220 [TBL] [Abstract][Full Text] [Related]
26. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients. Chong PP; Avery RK Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095 [TBL] [Abstract][Full Text] [Related]
27. Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial. Hao B; Chen Z; Zeng G; Huang L; Luan C; Xie Z; Chen J; Bao M; Tian X; Xu B; Wang Y; Wu J; Xia S; Yuan L; Huang J Clin Microbiol Infect; 2019 Aug; 25(8):1026-1031. PubMed ID: 30616012 [TBL] [Abstract][Full Text] [Related]
28. Immunization of healthy adults with live attenuated varicella vaccine. Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577 [TBL] [Abstract][Full Text] [Related]
29. Live attenuated varicella vaccine use in immunocompromised children and adults. Gershon AA; Steinberg SP; Gelb L Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495 [TBL] [Abstract][Full Text] [Related]
30. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Danziger-Isakov L; Kumar D; Clin Transplant; 2019 Sep; 33(9):e13563. PubMed ID: 31002409 [TBL] [Abstract][Full Text] [Related]
31. Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis. Kreth HW; Hoeger PH; Eur J Pediatr; 2006 Oct; 165(10):677-83. PubMed ID: 16835758 [TBL] [Abstract][Full Text] [Related]
32. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy. Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480 [TBL] [Abstract][Full Text] [Related]
34. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819 [TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study. Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656 [TBL] [Abstract][Full Text] [Related]
36. Live attenuated varicella vaccine. Gershon AA Annu Rev Med; 1987; 38():41-50. PubMed ID: 3034136 [TBL] [Abstract][Full Text] [Related]
37. Development of a skin- and neuro-attenuated live vaccine for varicella. Wang W; Pan D; Fu W; Ye X; Han J; Yang L; Jia J; Liu J; Zhu R; Zhang Y; Liu C; Ye J; Selariu A; Que Y; Zhao Q; Wu T; Li Y; Zhang J; Cheng T; Zhu H; Xia N Nat Commun; 2022 Feb; 13(1):824. PubMed ID: 35149692 [TBL] [Abstract][Full Text] [Related]
38. Live attenuated varicella vaccine. Arvin AM; Gershon AA Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076 [TBL] [Abstract][Full Text] [Related]
39. A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission. Gershon AA; Steinberg S; Gelb L; Galasso G; Borkowsky W; LaRussa P; Ferrara A Postgrad Med J; 1985; 61 Suppl 4():73-8. PubMed ID: 3014482 [TBL] [Abstract][Full Text] [Related]
40. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M; Güris D; Chaves SS; Schmid S; Seward JF; MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]